Skip to main content
SpringerLink
Log in

Circulating immune complexes in malignant diseases increased detection rate by simultaneous use of three assay methods

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

By using three different assay methods, circulating immune complexes have been detected in 85% of sera from patients with malignant melanoma, and in 77% of sera from patients with breast cancer. These methods were a C1q-binding assay, a double-antibody conglutinin-binding ELISA, and a polyethylene glycol 6000 precipitation technique followed by quantitative determination of immunoglobulins in the redissolved precipitate. Detection rates of circulating immune complexes using any one of these methods separately ranged from 33% to 56%, indicating the presence of different types of circulating immune complexes in cancer patients' sera. The combined use of the three methods mentioned resulted in an increased diagnostic sensitivity and a doubling of the predictive value. However, tests for circulating immune complexes cannot be considered as useful parameters for early diagnosis of cancer, since the comparatively low incidence of malignancies in the population at large, together with the presence of circulating immune complexes in other, nonmalignant, diseases of considerable prevalence, appears to preclude effective application of any nonspecific method for early diagnosis of cancer in general.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baldwin RW. Embleton MJ, Robins RA (1973) Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumor status. Int J Cancer 11:1–10

    Google Scholar 

  2. Baruth B, Caputo MJ, Deicher H, Leyssens H (1978) Quantitative Bestimmung von Serum-Proteinen in einem neuen Laser-Nephelometer. J Clin Chem Clin Biochem 16:397–402

    Google Scholar 

  3. Büttner J (1977) Die Beurteilung des diagnostischen Wertes klinisch-chemischer Untersuchungen. J Clin Chem Clin Biochem 15:1–12

    Google Scholar 

  4. Carpentier NA, Fiere DM, Schuh D, Lange GT, Lambert PH (1982) Circulating immune complexes and the prognosis of acute myeloid leukemia. N Engl J Med 4:1174–1180

    Google Scholar 

  5. Casali P, Bossus A, Carpentier NA, Lambert PH (1977) Solid-phase enzyme immunoassay or radio immunoassay for the detection of immune complexes based on their recognition by conglutinin: Conglutinin-binding test. Clin Exp Immunol 29:342–354

    Google Scholar 

  6. Gauci L, Ursule E, Pujol H, Serrou B (1979) Clinical implications of elevated levels of circulating immune complexes in patients with malignant melanoma. In: Peeters H (ed) Protides of the biological fluids. Pergamon Press, Oxford New York, pp 349–352

    Google Scholar 

  7. Gropp C, Havemann K, Schärfe T, Schulz H, Schaumlöffel E (1979) Zirkulierende Immunkomplexe beim Bronchialkarzinom: Beziehungen zum Ausbreitungsstadium der Erkrankung und zur Therapie. Klin Wochenschr 57:401–409

    Google Scholar 

  8. Hamburger Krebsdokumentation 1972–1974. Statistik des hamburgischen Staates, Heft 16

  9. Havemann K, Gropp C, Scheuer A, Scherfe T, Gramse M (1979) ACTH-like activity in immune complexes of patients with oat-cell carcinoma of the lung. Br J Cancer Br J Cancer 39:43

    Google Scholar 

  10. Heusser C, Boesmann M Nordin JH Islike H (1973) Effect of chemical and enzymatic radioiodination on the in vitro human C1q activities. J Immunol 110:820–827

    Google Scholar 

  11. Höffken K, Meredith ID, Robins RA, Baldwin RW, Davies CJ, Blamey RW (1977) Circulating immune complexes in patients with breast cancer. Br Med J II:218–220

    Google Scholar 

  12. Imai K, Ng AK, Ferrone S (1981) Characterization of monoclonal antibodies to human tumour-associated antigens. J Natl Cancer Inst 66:489

    Google Scholar 

  13. Krapf F, Renger D, Schedel I, Kemper A, Deicher H (1982) Lasernephelometric detection and characterization of CIC in human sera. J Immunol Methods 54:107–117

    Google Scholar 

  14. Lambert PH, Dixon FJ, Zubler RH, Agnello V, Cambiaso C, Casali P, Clarke J, Cowdery JS, McDuffie FC, Hay FC, MacLennan ICM, Masson P, Müller-Eberhard HJ, Penttinen K, Smith M, Tappeiner G, Theofilopoulos AN, Verroust P (1978) A WHO collaborative study for the evaluation of eighteen methods for detecting immune complexes in serum. J Clin Lab Immunol 1:1–15

    Google Scholar 

  15. Luthra HS, McDuffie FC, Hunder GG, et al. (1975) Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monoclonal rheumatoid factor. J Clin Invest 56:458–466

    Google Scholar 

  16. MacLennan ICM (1972) Competition for receptors for immunoglobulins on cytotoxic lymphocytes. Clin Exp Immunol 10:275–283

    Google Scholar 

  17. Myllylä G (1973) Aggregation of human blood platelets by immune complexes in the sedimentation pattern test. Scand J Haematol Suppl 19

  18. Nydegger UE, Lambert PH, Gerber H, Miescher PA (1974) Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. J Clin Invest 54:297–309

    Google Scholar 

  19. Onyewotu II, Holborow EJ, Johnson GD (1974) Detection and radioassay of soluble circulating immune complexes using guinea pig peritoneal exudate cells. Nature 248:156–159

    Google Scholar 

  20. Papsidero LD, Nemoto T, Synderman MC, Chu TM (1979) Immune complexes in breast cancer patients detected by C1q binding. Cancer 44:1636

    Google Scholar 

  21. Pereira AB, Theofilopoulos AN, Dixon FJ (1980) Detection and partial characterization of circulating immune complexes with solid-phase anti-C3. J Immunol 125:763–770

    Google Scholar 

  22. Rossen RD, Reisberg MA, Hersh EM, Gutterman JU (1977) The C1q binding test for soluble immune complexes: Clinical correlations obtained in patients with cancer. J Natl Cancer Inst 58:1205

    Google Scholar 

  23. Schedel I, Geissler K, Baruth B, Deicher H (1979) Circulating immune complexes in multiple myeloma. In: Peeters H (ed) Protides of the biological fluids. Pergamon Press, Oxford New York, pp 367–370

    Google Scholar 

  24. Schedel I, Peest D, Stünkel K, Fricke M, Eckert G, Deicher H (1980) Idiotype-bearing peripheral blood lymphocytes in human multiple myeloma and Waldenström's macroglobulinemia. Scand J Immunol 11:437–444

    Google Scholar 

  25. Theofilopoulos AN (1970) Evaluation and clinical significance of circulating immune complexes. Prog Clin Immunol 4:63–107

    Google Scholar 

  26. Theofilopoulos AN, Wilson CB, Dixon FJ (1976) The Raji cell radio immune assay for detecting immune complexes in human sera. J Clin Invest 57:169–182

    Google Scholar 

  27. Tung KSK, DeHoratius RJ, Williams RC Jr (1981) Study of circulating immune complex size in systemic lupus erythematosus. Clin Exp Immunol 43:515–625

    Google Scholar 

  28. Vecchio TJ (1966) Predictive value of a single diagnostic test in unselected populations. N Engl J Med 274:1171–1173

    Google Scholar 

  29. Volanakis J, Stroud RM (1972) Rabbit C1q: Purification, functional and structural studies. J Immunol Methods 2:25

    Google Scholar 

  30. World Health Organization (1977) The role of immune complexes in disease. WHO, Geneva (Technical report series, no 607)

    Google Scholar 

  31. Zubler RH, Lange G, Lambert PH, Miescher PA (1976) Detection of immune complexes in unheated sera by a modified 125J-C1q binding test. J Immunol 116:235

    Google Scholar 

  32. Zubler RH, Nydegger U, Perrin LH et al. (1976) Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125J-C1q binding activity with clinical and biological features of the disease. J Clin Invest 37:1305–1319

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section for Immunology and Transfusion Medicine Department of Internal Medicine and Dermatology, Hannover Medical College, Karl-Wiechert-Allee 9, D-3000, Hanover 61, Federal Republic of Germany

    F. Krapf, D. Renger, I. Schedel, M. Fricke, A. Kemper & H. Deicher

Authors
  1. F. Krapf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Renger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Schedel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Fricke
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Kemper
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Deicher
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krapf, F., Renger, D., Schedel, I. et al. Circulating immune complexes in malignant diseases increased detection rate by simultaneous use of three assay methods. Cancer Immunol Immunother 15, 138–143 (1983). https://doi.org/10.1007/BF00199705

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199705

Keywords

Search

Navigation